Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19 (2022)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/microorganisms10081639

PubMed Identifier: 36014057

Publication URI: http://europepmc.org/abstract/MED/36014057

Type: Journal Article/Review

Parent Publication: Microorganisms

Issue: 8